Andrea Calenne

Pharmadoo

BIOGRAPHY

Andrea Calenne is the Founder of Pharmadoo, supporting clients on product launches, lifecycle management, and operational buildouts. She brings over 25 years of experience in biotech, pharma, and food, with technical depth across drug substance, aseptic filling, and external manufacturing.

Andrea contributed to the FDA and PMDA approvals of Spinraza, the first-in-class therapy for spinal muscular atrophy. Her earlier roles covered the industrialization, filing, and launch of Alprolix and Eloctate. Both were the first recombinant long-acting treatments for hemophilia A and B.